comparemela.com
Home
Live Updates
Marshall Urist - Breaking News
Pages:
Latest Breaking News On - Marshall urist - Page 6 : comparemela.com
Repros Therapeutics (RPRX) Q1 2021 Earnings Call Transcript
RPRX earnings call for the period ending March 31, 2021.
United states
Chris neyor
Greg gilbert
America merrill lynch
Greg gilbert truist
Christopher schott
George grofik
Terence flynn goldman sachs
Jim reddoch
Terry coyne
Pablo legorreta
Chris schott
Terence flynn
Roche evrysdi
Marshall urist
Geoff meacham
Repros Therapeutics (RPRX) Q4 2020 Earnings Call Transcript
Repros Therapeutics (RPRX) Q4 2020 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble. Repros Therapeutics (NASDAQ: RPRX) Ladies and gentlemen, thank you for standing by. Welcome to the Royalty Pharma fourth-quarter 2020 financial results conference call. I would now like to turn the call over to George Grofik, senior vice president, head of investor relations and communications. Please go ahead, sir. George Grofik Senior Vice President, Head of Investor Relations and Communications. Thank you, operator, and good morning and good afternoon to everyone on the call. Thank you for joining us to review Royalty Pharma s fourth-quarter results. You can find the slides of this call on the investors page of our website at royaltypharma.com. Moving to Slide 3.
David risinger
Terence flynn goldman sachs
Jim reddoch
Terry coyne
Pablo legorreta
Terence flynn
Geoff meacham
Steve scala cowen
Steve scala
America merrill lynch
Mike difiore
George grofik
Gregg gilbert
Mike difiore evercore
David risinger morgan stanley
Chris schott
vimarsana © 2020. All Rights Reserved.